HuGE Literature Finder
Records
1
-
30
| Differences in actionable genomic alterations between brain metastases and non?brain metastases in patients with non?small cell lung cancer. International journal of oncology 2022 Sep 61 (3): . Nian Rui, Jiang Huihui, Zhao Jiangman, Hou Wanle, Zhang Hua, Ma Jiangtao, Lv Pengbiao, Jiang Lisha, Wang Yongpan, Xu Yue, Wu Shouxin, Lou Jingwei, Li Wanj |
| Association between long non-coding RNA HOTAIR polymorphism and lung cancer risk: A systematic review and meta-analysis. Experimental and therapeutic medicine 2022 Aug 24 (2): 540. Ke Chunlin, Feng Xuegang, Li Jie, Chen Siyu, Hu Xin |
| Age-dependent genomic characteristics and their impact on immunotherapy in lung adenocarcinoma. Journal of cancer research and clinical oncology 2022 Jul . Li Peng, Che Shuyu, Qi Yingxue, Luo Ningning, Lin Qiuju, Zhu Xiaofeng, Xuan Yunpeng, Li Mengmeng, Li Jinlong, Ge Minghui, Sun Tingting, Qi Chuang, Wang Yongj |
| Clinicopathologic and genomic features of high-grade pattern and their subclasses in lung adenocarcinoma. Lung cancer (Amsterdam, Netherlands) 2022 Jul 170 176-184. Ahn Bokyung, Yoon Shinkyo, Kim Deokhoon, Chun Sung-Min, Lee Goeun, Kim Hyeong-Ryul, Jin Jang Se, Sang Hwang H |
| Comparison of the somatic mutations between circulating tumor DNA and tissue DNA in Chinese patients with non-small cell lung cancer. The International journal of biological markers 2022 Jul 3936155221099036. Zhang Meng, Feng Yi, Qu Changda, Meng Meizhu, Li Wenmei, Ye Meiying, Li Sisi, Li Shaolei, Ma Yuanyuan, Wu Nan, Jia Shuq |
| Mendelian randomization study indicates lack of causal associations between iron status and lung cancer. Medicine 2022 Jul 101 (29): e29879. Qin Hong, Zeng Weibiao, Lou Yong |
| No association between polygenic risk scores for cancer and development of radiotherapy toxicity. International journal of radiation oncology, biology, physics 2022 Jul . Barnett Gillian C, Kerns Sarah L, Dorling Leila, Fachal Laura, Aguado-Barrera Miguel E, Martínez-Calvo Laura, Jandu Harkeran K, Welsh Ceilidh, Tyrer Jonathan, Coles Charlotte E, Haviland Joanne S, Parker Christopher, Gómez-Caamaño Antonio, Calvo-Crespo Patricia, Sosa-Fajardo Paloma, Burnet Neil G, Summersgill Holly, Webb Adam, De Ruysscher Dirk, Seibold Petra, Chang-Claude Jenny, Talbot Christopher J, Rattay Tim, Parliament Matthew, De Ruyck Kim, Rosenstein Barry S, Pharoah Paul D P, Dunning Alison M, Vega Ana, West Catharine M |
| Primary lesion radiotherapy during first-line icotinib treatment in EGFR-mutated NSCLC patients with multiple metastases and no brain metastases: a single-center retrospective study. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 2022 Jul . Deng Rui, Liu Jinkun, Song Tongjun, Xu Tao, Li Yong, Duo Long, Xiang Longchao, Yu Xiongjie, Lei Jinhua, Cao Fengj |
| Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancer. BMC cancer 2022 Jul 22 (1): 775. Matsumoto Yoshiya, Kawaguchi Tomoya, Watanabe Masaru, Isa Shun-Ichi, Ando Masahiko, Tamiya Akihiro, Kubo Akihito, Kitagawa Chiyoe, Yoshimoto Naoki, Koh Yasuhi |
| Prospective evaluation of the relationship between response and exposure of total and unbound erlotinib in non-small cell lung cancer patients. Cancer chemotherapy and pharmacology 2022 Jul . Kenmotsu Hirotsugu, Imamura Chiyo K, Kawamura Takahisa, Oyakawa Takuya, Omori Shota, Nakashima Kazuhisa, Wakuda Kazushige, Ono Akira, Taira Tetsuhiko, Naito Tateaki, Murakami Haruyasu, Yamamoto Nobuyuki, Takahashi Toshiaki, Tanigawara Yusu |
| Psoriasis may increase the risk of lung cancer: A two-sample Mendelian randomization study. Journal of the European Academy of Dermatology and Venereology : JEADV 2022 Jul . Luo Qiang, Chen Jie, Qin Li, Luo Yong, Zhang Yiwen, Yang Xiaoqian, Wang H |
| RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR-mutated metastatic non-small cell lung cancer: exposure-response relationship. Cancer chemotherapy and pharmacology 2022 Jul . Nakagawa Kazuhiko, Garon Edward B, Gao Ling, Callies Sophie, Zimmermann Annamaria, Walgren Richard, Visseren-Grul Carla, Reck Mart |
| Significant Contribution of Interleukin-18 Genotypes to Lung Cancer Risk in Taiwanese. Anticancer research 2022 Jul 42 (7): 3381-3387. Wu Meng-Feng, Chen Li-Hsiou, Hsia Ning-Yi, Shen Yi-Cheng, Shen Te-Chun, Wang Zhi-Hong, Yang Ya-Chen, Wang Yun-Chi, Chang Wen-Shin, Hsia Te-Chun, Bau DA-Tian, Tsai Chia-W |
| Structural, functional analysis and association of MSH6 rs1800932, rs1042821 polymorphisms with clinical outcome in North Indian lung cancer patients treated with platinum-based doublet chemotherapy. The American journal of the medical sciences 2022 Jul . Singh Sidhartha, Singh Navneet, Baranwal Manoj, Sharma Siddhar |
| Variants of ERCC5 and the outcome of platinum-based regimens in non-small cell lung cancer: a prospective cohort study. Medical oncology (Northwood, London, England) 2022 Jul 39 (10): 152. Abdalkhalek Esraa S, Wakeel Lamia M El, Nagy Ahmed A, Sabri Nagwa |
| Afatinib 30 mg in the treatment of common and uncommon Journal of thoracic disease 2022 Jun 14 (6): 2169-2177. Qian Jie, Ye Xuanting, Huang Aimi, Qin Ruoyan, Cai Yuqing, Xue Yiqian, Zhang Shi, Wang Weimin, Xiong Liwen, Gu Aiq |
| Deciphering associations between three RNA splicing-related genetic variants and lung cancer risk. NPJ precision oncology 2022 Jun 6 (1): 48. Yang Wenjun, Liu Hongliang, Zhang Ruoxin, Freedman Jennifer A, Han Younghun, Hung Rayjean J, Brhane Yonathan, McLaughlin John, Brennan Paul, Bickeboeller Heike, Rosenberger Albert, Houlston Richard S, Caporaso Neil E, Landi Maria Teresa, Brueske Irene, Risch Angela, Christiani David C, Amos Christopher I, Chen Xiaoxin, Patierno Steven R, Wei Qing |
| Development and validation of a blood-based genomic mutation signature to predict the clinical outcomes of atezolizumab therapy in NSCLC. Lung cancer (Amsterdam, Netherlands) 2022 Jun 170 148-155. Liu Manjiao, Xia Sijian, Zhang Xu, Zhang Bei, Yan Linlin, Yang Meijia, Ren Yong, Guo Hao, Zhao J |
| Upfront Next Generation Sequencing in Non-Small Cell Lung Cancer. Current oncology (Toronto, Ont.) 2022 Jun 29 (7): 4428-4437. Kuang Shelley, Fung Andrea S, Perdrizet Kirstin A, Chen Kaitlin, Li Janice J N, Le Lisa W, Cabanero Michael, Karsaneh Ola Abu Al, Tsao Ming S, Morganstein Josh, Ranich Laura, Smith Adam C, Wei Cuihong, Cheung Carol, Shepherd Frances A, Liu Geoffrey, Bradbury Penelope, Pal Prodipto, Schwock Joerg, Sacher Adrian G, Law Jennifer H, Stockley Tracy L, Leighl Natasha |
| Efficacy of Osimertinib in EGFR-Mutated Advanced Non-small-Cell Lung Cancer With Different T790M Status Following Resistance to Prior EGFR-TKIs: A Systematic Review and Meta-analysis. Frontiers in oncology 2022 12 863666. Yi Xiao-Fang, Song Jun, Gao Ruo-Lin, Sun Li, Wu Zhi-Xuan, Zhang Shu-Ling, Huang Le-Tian, Ma Jie-Tao, Han Cheng- |
| Gene Mutation and Its Association with Clinicopathological Features in Young Patients with Non-Small-Cell Lung Cancer. Emergency medicine international 2022 2022 6333282. Kong Wencui, Yu Zongyang, Wang Wenwu, Yang Jingrong, Wang Jingfang, Zhao Zhongqu |
| Genetic Polymorphisms in CYP2C19 Cause Changes in Plasma Levels and Adverse Reactions to Anlotinib in Chinese Patients With Lung Cancer. Frontiers in pharmacology 2022 13 918219. Tan Tingfei, Han Gongwei, Cheng Ziwei, Jiang Jiemei, Zhang Li, Xia Zitong, Wang Xinmeng, Xia Qu |
| Genomic Alterations Identification and Resistance Mechanisms Exploration of NSCLC With Central Nervous System Metastases Using Liquid Biopsy of Cerebrospinal Fluid: A Real-World Study. Frontiers in oncology 2022 12 889591. Shen Fangfang, Liang Naixin, Fan Zaiwen, Zhao Min, Kang Jing, Wang Xifang, Hu Qun, Mu Yongping, Wang Kai, Yuan Mingming, Chen Rongrong, Guo Wei, Dong Guilan, Zhao Jun, Bai J |
| Molecular and Clinicopathological Characteristics of Lung Cancer Concomitant Chronic Obstructive Pulmonary Disease (COPD). International journal of chronic obstructive pulmonary disease 2022 17 1601-1612. Ma Hongxia, Zhang Qian, Zhao Yanwen, Zhang Yaohui, Zhang Jingjing, Chen Guoqing, Tan Yuan, Zhang Qin, Duan Qianqian, Sun Tingting, Qi Chuang, Li Fengs |
| Optimizing Patient Outcomes Through Sequential EGFR TKI Treatment in Asian Patients With Clinical Medicine Insights. Oncology 2022 16 11795549221103215. Liu Rong, Zhou Jianying, Ling X |
| Peruvoside is a novel Src inhibitor that suppresses NSCLC cell growth and motility by downregulating multiple Src-EGFR-related pathways. American journal of cancer research 2022 12 (6): 2576-2593. Lai Yihua, Chang Hsiuhui, Chen Hueiwen, Chang Geechen, Chen Jeremy |
| Prognostic outcome of treatment modalities for epidermal growth factor receptor-mutated advanced lung cancer. The Korean journal of internal medicine 2022 07 37 (4): 811-820. Jang Seung Hun, Lee Dong Yoon, Jeong Jihyeon, Choi Won- |
| A brief report on the mutational landscape in non-small cell lung cancer of South Asian patients: Comparison at a US and an Indian Institution. Lung India : official organ of Indian Chest Society 0 39 (4): 315-318. Roy Mohana, Bal Amanjit, Gupta Nalini, Prasad Kuruswamy T, Wakelee Heather A, Singh Navne |
| Concordance analysis between liquid biopsy (ctDNA) and tumor DNA molecular profiles from panel-based next-generation sequencing. Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia 0 55 (3): 156-162. Rodon Font Natalia, No Garbarino Yessica, Díaz Castello Olga, Moya Amoros Juan, Barrios Sánchez Pedro, Coroleu Lletget David, Lequerica Cabello Mª Antonia, Borras Marcet Joan, Mecho Meca Sandra, Escape Isabel, Martinez-Agea Javier, Garcia Estefania, Ferrer Marta, Puig Torrus Xavi |
| Low-Cost Genetic and Clinical Predictors of Response and Toxicity of Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer. Dose-response : a publication of International Hormesis Society 0 20 (2): 15593258221111666. Spasic Jelena, Cavic Milena, Stanic Nemanja, Zaric Bojan, Kovacevic Tomi, Radosavljevic Davorin, Nagorni-Obradovic Ljudmi |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 10, 2022
- Content source: